Background {#Sec1}
==========

The emergence of multidrug-resistant Gram-negative bacteria is a major concern in hospital settings in many parts of the world. Infections caused by these pathogens have become significantly challenging over the past two decades, particularly in the developing countries, and are associated with high morbidity and mortality rates as well as protracted hospital stay \[[@CR1]\]. Enterobacteriaceae including *Klebsiella pneumoniae*, *Escherichia coli* as well as *Enterobacter spp.* and non-lactose fermenting bacteria such as *Pseudomonas aeruginosa* and *Acinetobacter spp.* have been identified as major cause of multi-drug resistant bacterial infections \[[@CR2]--[@CR4]\].

Studies conducted in many developing countries including Africa, have indicated high antibiotic resistance among Gram-negative bacteria to commonly used antibiotics, leading to a loss of efficacy for treatment of common infections \[[@CR5]--[@CR7]\]. These resistant bacterial pathogens are a major cause of both community and hospital-acquired infections. Respiratory tract, urinary tract, bloodstream (septic), post-surgical (wound) infections and pneumonia are among most commonly reported infections attributable to these pathogens in many hospitals \[[@CR8]\].

Although, the impact of antibiotic resistance caused by multidrug resistant Gram-negative bacteria has been recognised in hospitals in Ghana, measures such as surveillance studies that provide reliable data to mitigate the problem are not in place. Therefore studies to establish the prevalence and extent of resistance are necessary to bridge the information gap and provide the basis to guide empiric therapy. This study aimed to assess multidrug-resistance among Gram-negative bacteria in Komfo Anokye Teaching Hospital in Ghana to guide treatment protocols. The data further provides a baseline for future comparative studies.

Materials {#Sec2}
=========

Setting of study {#Sec3}
----------------

The study was conducted between February and August 2015, in Komfo Anokye Teaching Hospital (KATH) in Kumasi, in the Ashanti region of Ghana. The facility is a 1000-bed tertiary care government hospital. The average daily primary care and specialist outpatient attendance was 169 and 954 patients respectively, during the period of study. The population of the region is concentrated in a few districts, with the Kumasi metropolis accounting for nearly one-third of the region's population of 4,780,380 \[[@CR9]\]. KATH is the only regional and referral hospital that takes care of about 80% of both emergencies and regular medical cases in the region and serves as referral hospital for part of Brong Ahafo, Western, Eastern and the Northern regions of Ghana.

Bacterial collection and identification {#Sec4}
---------------------------------------

Two hundred (200) clinical, non-duplicate Gram-negative bacteria were randomly selected from urine, pus, wound swab, pleural fluid endotracheal tubes, gastric lavage and blood specimens processed by the diagnostic microbiological laboratory in the hospital from both in-patients and out-patients. Information on diagnosis, sex, age and ward type were obtained from patients records. The isolates were maintained on nutrient agar slants, frozen in lyophilizing medium at − 70 °C and subsequently transported to National Health Laboratory Services in South Africa to confirm identification and ascertain antibiotic susceptibility profiles using Vitek-2 (Biomerieux, France) Automated Systems with *P. aeruginosa* ATCC27853 and *E.coli* ATCC35218 as control strains. Multidrug-resistance in this study was defined as isolates that were resistant to at least one agent in three or more antibiotic classes.

Results {#Sec5}
=======

Of the 200 resistant Gram-negative bacterial isolates obtained, *E. coli* was most frequent pathogen 49 (24.5%), followed by *P. aeruginosa* 39 (19.5%), *K. pneumoniae* 38 (19.0%), *Enterobacter spp*. 12 (6.0%) *Serratia spp.* 8 (4.0%), *Sphingimonas spp.* 10 (5.0%) and *Acinetobacter spp.* 8 (4.0%). The remaining 36 (18%) (Table [1](#Tab1){ref-type="table"}) consisted of *Yersinia spp.* (5) *Proteus mirabilis* (1), *Salmomella enterica* (1), *Vibrio spp.* (5), *Citrobacter koseri* (3), *Pantoea* spp. (5), *Providencia rettgeri* (4), *Pasteurella spp.* (2) *Chromobacterium violaceum* (2), *Burkholderia cepacia* (2), *Aeromonas spp.* (5), *Cadecea lapagei* (1). The distribution of the specimen types showed highest proportion of isolates, were from urine specimens 94 (47.0%), followed by wound swabs 45 (22.5%) and sputum 24 (12.0%) with just 1 (0.5%) from each of bronchial lavage, nasal and pleural swabs respectively. A higher proportion of isolates were recovered from in-patients 161 (80.5%) compared to the out-patients 39 (19.5%). The number of isolates from the medical intensive care unit (ICU) 78 (39.0%) was highest, followed by Child Health 39 (19.5%) and the Obstetrics and Gynecology wards 17 (8.5%) with the smallest number of 10 (5.0%) isolated in the Accident and Emergency Unit. *E. coli* 49 (24.5%), *P. aeruginosa* 39 (19.5%) and *K. pneumoniae* 38 (19.0%) (Table [1](#Tab1){ref-type="table"}) were the most predominant pathogens implicated in 63.0% of all infections. The distribution of bacterial pathogens among clinical diagnosis showed urinary tract infection (UTI) 69 (34.5%) as the most prevalent, followed by sepsis 29 (14.5%), tuberculosis 18 (9.0%) and wound infections 12 (6.0%) with the least prevalence in appendicitis, bacteremia, cystitis and prostitis 1 (0.5%) (Table [1](#Tab1){ref-type="table"}). *E. coli* 24 (34.8) was identified as most common cause of UTI, followed by *K. pneumoniae* 17 (24.6%) and *P. aeruginosa* 9 (13.04%) implicated in 72.4% of all UTI pathogens.Table 1Distribution of isolates among clinical specimen, wards and diagnosisIsolates (*N*)*Acinetobacter sppE. coliEnterobacter sppK. pneumoniaP. aeruginosaSerretia sppSphingimonas spp*Other\*Total (%)Specimen Asctic fluid--------------11 (0.5) Aspirate--211--------4 (2.0) Blood--122------611 (5.5) Bronchial Lavage----1----------1 (0.5) Ear Swab--1--111--26 (3.0) Gastric Lavage------11----24 (2.0) Nasal Swab--------1------1 (0.5) Pleural Fluid------1----1--2 (1.0) Pus--3--------115 (2.5) Sputum--333832224 (12.0) Urethral Swab2--------------2 (1.0) Urine6355231244594 (47.0) Wound Swab--4616--31645 (22.5)WARD/DEPT A &E12--2211110 (5.0) Child Health1123113--1839 (19.5) Medical ICU21461021541678 (39.0) OBS &GYN2324211217 (8.5) OPD21219513639 (19.5) Surgery--6--26----317 (8.5)Diagnosis Abscess--11111--27 (3.5) Appendicitis--1------------1 (0.5) Bacteremia--1------------1 (0.5) Bronchitis------11------2 (1.0) Cellulitis--------------11 (0.5) Cirrhosis--11----------2 (1.0) Cystitis------1--------1 (0.5) Diabetic foot ulcer--11--4--1310 (5.0) Gastroenteritis--4--1--------5 (2.5) Nephritis--6--3--1--111 (5.5) Otitis--1----------12 (1.0) Pericarditis--1----2------3 (1.5) Peritonitis--1----1------2 (1.0) Pneumoniae------1--21--4 (2.0) Prostitis----------1----1 (0.5) RTI------11--215 (2.5) Sepsis1614423829 (14.5) Surg. site infection--1--44----110 (5.0) Tuberculosis--142**7**11218 (9.0) UTI7244179--2669 (34.5) Ulcer--------1----12 (1.0) Wound infection------14----712 (6.0)Frequency (%)**8 (4.0)49 (24.5)12 (6.0)38 (19.0)39 (19.5)8 (4.0)10 (5.0)36 (18.0)200 (100)***Abbreviation*: *A&E* Accident and Emergency, *OPD* Out-Patient Department, *OBS&GYN* Obstetrics and Gynecology, *Other\** Other Gram-negative bacteria. The In-Patient Department comprises of A&E, Medical ICU, OBS&GYN and Surgical ward, −: Non-detected

Demographic characteristics of patients with bacterial infections {#Sec6}
-----------------------------------------------------------------

The patients' ages ranged between 2 months to 90 years and mean age was 35.95 ± 27.11 years with the gender distribution of 101 (50.5%) males and 99 (49.5%) females. Samples from outpatients (OPD) made up 19.5% of the total samples. All the other samples (80.5%) from Accident and Emergency, Child Health, Medical ICU, Surgery and Obstetrics and Gynaecology departments were inpatient samples (Table [1](#Tab1){ref-type="table"}). The prevalence of infections were highest among the patients of age-group ≥60 years 49 (24.5%) followed by \< 10 years 48 (24.0%), 20--29 years 26 (13.0), 30--39 years and least in 50--59 years 17 (8.5%) (Table [2](#Tab2){ref-type="table"}). UTI was highest among the age-group \< 10 years 23 (33.3%) followed by 30--39 years 12 (17.4%) and least 50--59 years 4 (5.8%). Septic infection was highest in patients within the age-group \< 10 years 8 (40.0%), followed by ≥60 years 5 (25.0%) least in 10--19 years 3 (15.0%) (Table [2](#Tab2){ref-type="table"}). Among the different types of wound infections, diabetic foot ulcer showed high proportion within age-groups 50--59 and ≥60 years of patients.Table 2Distribution of infections among gender and patients' age groupsAge (Years)\
Number of Cases (*N*)\< 1010--1920--2930--3940--4950--59≥60Total (%)Gender Female21820131191799 (49.5) Male2711689832101 (50.1)Infections Abscess2121--1--7 (3.5) Appendicitis--1----------1 (0.5) Bacteremia1------------1 (0.5) Bronchitis1----------12 (1.0) Cellulitis------------11 (0.5) Cirrhosis--11--------21.0) Cystitis1------------1 (0.5) Diabetic foot ulcer----1--11710 (5.0) Gastroenteritis43----------7 (3.5) Nephritis--11111611 (3.5) Otitis1--1--------2 (1.0) Pericarditis--------2--13 (1.5) Peritonitis2------------2 (1.0) Pneumoniae--1--------34 (2.0) Prostitis------------11 (1.0) RTI21--11----5 (2.5) Sepsis831--12520 (10.0) Surgical wound infection1122--2210 (5.0) Tuberculosis113--63418 (9.0) UTI234101274969 (34.5) Ulcer--1----1----2 (1.0) Wound infection1--2212210 (5.0)Frequency (%)**48 (24.0)19 (9.5)26 (13.0)21 (10.5)20 (10.0)17 (8.5)49 (24.4)200 (100)***Abbreviation*: *UTI* Urinary tract infection, *RTI* Respiratory tract infection, −: Non-detected

Susceptibility profile {#Sec7}
----------------------

The antibiotic susceptibility profile showed that the isolates were most resistant to ampicillin (94.4%), trimethoprim/sulfamethoxazole (84.5%), cefuroxime/Axetil (80.0%), cefuroxime (79.0%), cefotaxime (71.3%), cefoxitin (57.5%) and were least resistant to ertapenem (1.5%) (Table [3](#Tab3){ref-type="table"}).Table 3Antibiotic susceptibility profile of isolatesAntibioticsTotal number of isolates (*N*)Susceptible *N* (%)Intermediate *N* (%)Resistant *N* (%)Ampicillin1627 (4.3)2 (1.2)153 (94.4)Amox/clav20051 (25.5)47 (23.5)102 (51.5)Piperacillin-tazobactam198109 (54.5)62 (31.0)27 (13.5)Cefuroxime20035 (17.5)7 (3.5)158 (79.0)Cefoxitin20074 (37.0)11 (5.5)115 (57.5)Cefotaxime19944 (22.1)12 (6.0)143 (71.3)Ceftazidime200104 (52.0)15 (7.5)81 (40.5)Cefepime200119 (59.5)64 (32.0)17 (8.5)Ertapenam132130 (98.5)1 (0.8)1 (0.8)Imipenem199191 (95.5)0 (0.0)8 (4.0)Meropenem198192 (97.0)1 (0.5)5 (2.5)Amikacin199178 (89.4)14 (7.0)7 (3.5)Gentamicin198105 (53.0)5 (2.5)88 (44.4)Ciprofloxacin200116 (58.0)2 (1.0)82 (41.0)Tetracycline199124 (62.3)14 (7.0)61 (30.7)Nitrofuratoin20084 (42.0)17 (8.5)99 (49.5)Collistin198164 (82.8)2 (1.0)32 (16.2)Trim/Sulfamethoxazole20031 (15.5)0 (0.0)169 (84.5)Not all the antibiotics were tested for all 200 isolates and not all *N*-values added up to 200*Abbreviation*: *amox/clav* amoxicillin-clavulanate, *trim/sulfamethoxazole* trimethoprim-sulfamethoxazole

### Multi-drug resistance {#Sec8}

Multidrug resistance was observed in 89.5% of the bacterial isolates, ranging from 53.8% in *Enterobacter* spp. to 100.0% in *Acinetobacter* spp. and *P. aeruginosa* (Table [4](#Tab4){ref-type="table"}).Table 4MDR among IsolatesBacterial IsolatesNumber of Isolates (*N*)MDR *N* (%)*Acinetobacter spp*88 (100.0)*E. coli*4944 (89.9)*Enterobacter spp*127 (53.8)*K. pneumoniae*3836 (94.7)*P. aeruginosa*3939 (100.0)*Serratia spp*87 (87.5)*Sphingomonas paucimobilis*109 (90.0)Other Gram negative3629 (80.6)Frequency**200179 (89.5)**

Discussion {#Sec9}
==========

Epidemiological surveillance of bacterial infection and resistance to antibiotics are essential for awareness creation, implementation of control measures and effective management of infections. This is important in developing countries particularly in sub-Saharan Africa where studies have indicated that many hospitals have rudimentary and poor enforcement of infection control measures and marginal awareness on the extent of infections caused by multi-drug resistant bacteria which have resulted in increased morbidity and mortality \[[@CR10], [@CR11]\].

Our study observed higher prevalence of infections among in-patients (80.5%) compared to the out-patients (19.5%), with ICU accounted for highest incidence. The frequency of bacterial pathogens isolated from male (50.5%) and female (49.5%) patients, showed no appreciable difference. The high infections of in-patients is consistent with the finding from nationwide surveillance on antimicrobial resistant pathogens from patients' blood cultures, which recorded prevalence of \> 70% of bacterial infections among in-patients in Ghanaian hospitals \[[@CR12]\]. Several predisposing factors are associated with the higher infection rates among hospitalized patients such as the use of invasive procedures like catheterization, central lines and mechanical ventilation \[[@CR13]\]. A number of risk factors account for the high ICU infections including non-compliance of care professionals (physicians and nurses) to hand-hygiene practices which has been identified in a study conducted in a neonatal ICU in a Ghanaian tertiary care hospital as a major factor contributing to healthcare infections in ICU \[[@CR14]\]. The ICU houses critically ill patients and are often exposed to extensive use of antibiotics causing selection pressure for the emergence of resistance. These factors coupled with interventional instrumentations such as mechanical ventilation and invasive procedures, commonly used in ICU \[[@CR15]\], exposes the patients to high risk of infections. KATH is the only tertiary and referral facility receiving patients into the ICU from many healthcare facilities within the region and other parts of the country, often resulting in congestion or overcrowding, thus increasing chances of transmitting infections among patients.

This study indicated high infections among advancing and infant age-groups with UTI and sepsis recorded as most frequent. The geriatric and pediatric patients are usually more disposed to infections due to their immune status. The advancing age are commonly associated with risk factors including reduced immunity, co-morbid diseases such as diabetes mellitus, chronic heart diseases, neurogenic bladder \[[@CR13], [@CR16]\] whilst in infants, lack of fully developed immunity, malnutrition as well as inadequate hygiene \[[@CR17]\] put them at greater risk of infections. Urinary tract infection (34.5%) was most prevalent within the period of our study, and is comparable to 31.5% reported from a study on prevalence and antibiotic susceptibility pattern of uropathogens conducted in secondary hospital in Ghana \[[@CR18]\]. Our study found, *E. coli* and *K. pneumoniae* as most predominant pathogens implicated in UTI. Several studies conducted in the region and other parts of the country have reported UTI as most common infections frequently caused by *E.coli* and *K. pneumoniae* with high resistance to broad spectrum antibiotics, that remains a major clinical problem in health care system in Ghana \[[@CR19], [@CR20]\]. Among the isolates, *E. coli*, *K. pneumoniae Proteus mirabilis*, *P. aeruginosa*, *Enterobacter*, *Acinetobacter* and *Serratia* spp. in the present study have been reported as clinically important urine pathogens \[[@CR18], [@CR21]\], associated with about 90% of both community and hospital acquired UTIs \[[@CR22], [@CR23]\]. Urinary tract infection prevalence was high among infants and the middle aged with incidence higher in females (10.8%) than the males (6.6%) in the middle age group. In infants predisposing factors such as lack of personal hygiene, incomplete emptying of the bladder with residual urine and severe acute malnutrition have been reported \[[@CR24]\], whilst the middle aged, in particular females, high parity coupled with increased frequency of sexual activities have been identified, contributing to the high incidence \[[@CR25]\]. The prevalence of sepsis among infants, 40.0% (Table [2](#Tab2){ref-type="table"}), was higher compared to the 25.9% previously reported in the country \[[@CR26]\]. The higher prevalence is attributed to higher patients' intake in the study site and also situated in most populous region, thus receiving higher numbers of patients (infants) with complications compared to other regions of Ghana. This study is however limited in its representativeness of the entire hospital because we did not systematically collect data on how much of each specimen type was sent to the lab and which types of isolates were obtained from each specimen type.

Among the isolates, *E. coli*, *P. aeruginosa* and *K. pneumoniae* were most prevalent pathogens implicated in 63.0% (Table [1](#Tab1){ref-type="table"}) of the infections with high resistance to antibiotics commonly used in Ghana. The finding that *E coli*, *P. aeruginosa* and *K. pneumoniae* were most prevalent Gram-negative pathogens is consistent with previous studies conducted in Ashanti region of Ghana \[[@CR20]\] and other parts of the country \[[@CR26], [@CR27]\]. A nationwide surveillance on antimicrobial resistant pathogens study, conducted by Opintan et al. also indicated *E.coli* and *P. aeruginosa*, *Enterobacter*, *Citrobacter spp.* and *K. pneumoniae* as most common gram-negative bacterial pathogens in Ghana \[[@CR28]\]. The current prioritized lists of bacterial pathogens by World Health Organization (WHO), categorized *E. coli*, *P. aeruginosa*, *K. pneumoniae*, *Acinetobacter*, *Enterobacter*, *Serratia*, *Proteus* and *Providencia* spp. identified in our study, as critical or most life-threatening Gram-negative pathogens under surveillance due to their high antibiotic resistance especially to carbapenems and third generation cephalosporins, associated with attributable mortality \[[@CR29]\]. In particular, *K. pneumoniae*, *P. aeruginosa*, *Acinetobacter* and *Enterobacter* spp. have further been described by the Infectious Diseases Society of America as Gram-negative ESKAPE (*Enterococcus faecium*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa* and *Enterobacter* spp) pathogens, frequently associated with multidrug resistance \[[@CR30], [@CR31]\]. These ESKAPE Gram-negative pathogens were implicated in 48.5% (Table [1](#Tab1){ref-type="table"}) of the infections which is higher than 35.6% previously reported \[[@CR27]\]. The pathogens were also implicated in 50% (Table [1](#Tab1){ref-type="table"}) of the ICU infections, and therefore posing a major threat to public healthcare in Ghana.

The susceptibility profile of the isolates displayed high level multidrug resistance of 89.5% with high resistance to ampicillin (94.4%), trimethoprim sulfamethoxazole (84.5%), cefuroxime (79.0%) cefotaxime (71.3%), cefoxitin (57.5%) and amoxacillin-clavulanate (51.5%) observed, was consistent with other studies conducted in Ghana \[[@CR27], [@CR32]\]. The degree of resistance among the isolates to ampicillin, trimethoprim/sulfamethoxazole and amoxacillin-clavulanate showed in the study, also agreed with other studies conducted in the sub-Sahara African countries such as Tanzania \[[@CR7]\], Nigeria \[[@CR33]\], Ethiopia \[[@CR34]\], Zimbabwe \[[@CR35]\] and Rwanda \[[@CR6]\]. The high resistance trend in the sub region is indicative of high antibiotic selection pressure largely due to relatively cheap and easy availability of these agents, mostly used as first line or common choice of treatment in many healthcare settings in the sub region \[[@CR36]--[@CR38]\].

The decreased susceptibility of isolates to the beta-lactam/beta-lactamases inhibitor combination antibiotic therapy and fluoroquinolones (ciprofloxacin) is comparable to other studies in Ghana \[[@CR20], [@CR27]\], which poses a challenge to treatment of common infections as these agents are readily available therapeutic options \[[@CR39]\]. The high resistance to second and third-generation cephalosporins (cefuroxime \[79.0%\], cefoxitin \[57.5%\] and cefotaxime \[71.3%\]), may suggest high expression or production of extended spectrum beta-lactamases among Gram-negative bacteria as previously reported in Ghana \[[@CR40]\]. The carbapenems (imipenem, ertapenem and meropenem), amikacin and colistin were sensitive, as these antibiotics are used as last resort in treatment of serious infections. In addition the carbapenems have been introduced into Ghanaian market for relatively short span of time and is comparatively more expensive than the mainstay antibiotics and therefore, not commonly used.

This has possibly led to relatively low natural selection and hence low development of antibiotic resistance among the isolates.

Conclusion {#Sec10}
==========

The study demonstrated high multidrug resistant Gram-negative bacteria implicated in the infections, with UTI as most frequently diagnosed among patients. Infections were common among the elderly and infants, and predominantly caused by *E. coli*, *K. pneumoniae* and *P*. *aeruginosa* during the period of our study. These results should inform the empirical treatment of infections in Komfo Anokye Teaching Hospital of Ghana as appropriate.

We would like to thank the Komfo Anokye Teaching Hospital staff, especially the technical staff in the Microbiology laboratory for their support during sample collection and preliminary identification, the Physicians and Nursing staff in various wards for their assistance. We also thank the staff of National Health Laboratory Services (NHLS), Albert Luthuli Hospital in South Africa for further bacteria identification and the antibiotics susceptibility profile testing.

Funding {#FPar1}
=======

This study was supported by the National Research Foundation Incentive Funding for Rated Researchers Grant No.: 85595 awarded to Professor S.Y. Essack and a PhD Scholarship awarded to N Agyepong by the College of Health Sciences, University of KwaZulu-Natal.

Availability of data and materials {#FPar2}
==================================

Data and materials have been provided in the main manuscript. Where necessary additional information of the study can be made available from the corresponding author on request.

The study was co-conceptualized and jointly designed by NA, AO and SE. NA collected the data and undertook laboratory analysis with the help from UG. NA analyzed and interpreted the data with assistance from AO & SE. All the authors contributed in preparation and submission of manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate {#FPar3}
==========================================

Ethical clearance was approved by the joint Committee of Human Research Publications and Ethics, School of Medical Sciences, Kwame Nkrumah University of Technology, Research and Development Unit of the Hospital Administration (ref: CHRPE/AP/015/15) and the Biomedical Research Ethics Committee of University of Kwa-Zulu Natal (ref: BE 494/14). Informed consent was obtained from all participants, and from parents or guardians for minors in written form either signed or by a thumb print after explanation of the procedure and the purpose of the study.

Consent for publication {#FPar4}
=======================

Not applicable

Competing interests {#FPar5}
===================

Professor Essack is a member of the Global Respiratory Infection Partnership sponsored by an unrestricted educational grant from Reckitt and Benckiser, UK. The other authors have no competing interest to declare.

Publisher's Note {#FPar6}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
